Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Flexion Therapeutics Announces Preliminary Unaudited Fourth Quarter And Full Year 2020 Results is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter ...
--Flexion Therapeutics, Inc. today announced preliminary and unaudited revenue for the fourth-quarter and full-year ended December 31, 2019 and provided initial revenue guidance for 2020.. “We ... Read More
Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2020 ...
The company reported a net loss of $113.7 million for full-year 2020 as compared to a net loss of $149.8 million for full-year 2019. Net sales of ZILRETTA were $26.3 million for fourth-quarter ... Read More
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter ...
--Flexion Therapeutics, Inc. today announced preliminary and unaudited net sales for the fourth quarter and full year ended December 31, 2020. “We are very pleased to report preliminary full ... Read More
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter ...
Fourth-quarter 2019 revenue estimated to be approximately $23.7 million Full-year 2019 revenue estimated to be approximately $73 million, representing year-over-year growth of more than 220% Flexion ... Read More
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter ...
Fourth-quarter 2019 revenue estimated to be approximately $23.7 million Full-year 2019 revenue estimated to be approximately $73 million, representing year-over-year growth of more than 220% ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus